J. Ficker (Nuremberg, Germany), J. Muller-Quernheim (Freiburg, Germany)
Airway granzyme B from CD8+ T-cells is related to severity of airflow obstruction in smokers
M. Boorsma, R. Lutter, A. Noorduyn, H. M. Jansen, R. E. Jonkers (Amsterdam, Netherlands)
|  |
Long-term immunological monitoring of COPD patients suffered from the Chornobyl catastrophe
K. D. Bazyka, V. A. Sushko (Kiev, Ukraine)
| |
Epithelial overexpression of interleukin-8 in bronchial biopsies from patients with COPD
F. Magno, G. Sivverini, I. Gnemmi, A. Capelli, S. E. D‘Anna, F. Cappello, P. Balbo, P. Brun, C. F. Donner, F. L. M. Ricciardolo, A. Di Stefano (Veruno, Cefalù, Palermo, Novara, Padova, Genova, Italy)
| |
Release of TGF β from sputum cell culture in COPD and asthma
L. J. Godinas, M. Henket, J. Sele, J. L. Corhay, R. E. Louis (Liege, Belgium)
| |
P-selectin glycoprotein ligand-1 expression on leukocytes from COPD patients and smokers
A. Schumacher, U. Liebers, M. Meyer, C. Witt, G. Wolff (Berlin, Hennigsdorf, Germany)
| |
Impaired mucosal immunity in COPD patients – workers of the radiochemical plant
E. I. Altynbaeva, G. L. Ignatova, S. N. Teplova, O. V. Galimova (Ozersk, Chelyabinsk, Russian Federation)
| |
The clinico-immunological evaluation of the ribomunyl therapy in complex treatment of COPD patients
Y. A. Smirnova, N. L. Shaporova, V. I. Trofimov, O. A. Ivanova (Saint Petersburg, Russian Federation)
| |
The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer
M. V. Fleming, N. V. Cherdyntseva, S. V. Miller (Tomsk, Russian Federation)
| |
Blood plasma levels of ascorbic acid in COPD
G. Ilonidis, I. Magoula, I. Paradias, E. Mandala, K. Kidonopoulou, A. Anogeianaki, C. Giannakoulas, G. Anogianakis (Thessaloniki, Greece)
| |
Airway inflammation in older people with mixed airway disease
P. G. Gibson, J. L. Simpson (Newcastle, Australia)
| |
Interleukin-17 (IL-17) contributes to silica-induced alveolitis but is not essential in fibrosis development
F. Huaux, C. van Vyve, B. Marien, P. Misson, S. van den Brûle, S. Kanaly, D. Lison (Brussels, Belgium; Seattle, United States Of America)
| |
Activation of discoidin domain receptor 1 on CD14 positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis
W. Matsuyama, M. Watanabe, K. I. Oonakahara, I. Higashimoto, M. Osame, K. Arimura (Kagoshima, Japan)
| |
5 year longitudinal study in a cohort of pigeon fanciers
T. Ismail, F. Boyd, P. Lynch, G. Boyd, C. McSharry (Shah Alam, Malaysia; Glasgow, United Kingdom)
| |
Clinical features of acute exacerbation in chronic birdfancier‘s lung
Y. Miyazaki, M. Kishi, Y. Ohtani, N. Inase, Y. Yoshizawa (Tokyo, Japan)
| |
The association of serum IgG antibody with symptoms of hypersensitivity pneumonitis
T. Ismail, P. Lynch, S. J. Bourke, K. Anderson, G. Boyd, C. McSharry (Shah Alam, Malaysia; Glasgow, Newcastle upon Tyne, Kilmarnock, United Kingdom)
| |
Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP)
J. Kuramochi, Y. Ohtani, N. Inase, H. Kawachi, M. Tamaoka, M. Furuie, S. Isogai, Y. Miyazaki, T. Takemura, S. Saiki, Y. Yoshizawa (Tokyo, Japan)
| |
Blood levels of TNF-α, IFN-γ, IL-10, TGF-β1 and lung functional parameters in patients with advanced and earlier lung sarcoidosis
T. P. Ses, O. P. Baranova, O. E. Baklanova, M. Y. Kameneva (Saint Petersburg, Russian Federation)
| |
Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS)
O. E. Baklanova, V. A. Voinov, K. S. Karchevskij, O. P. Baranova, T. P. Ses (Saint Petersburg, Russian Federation)
| |
HRCT imaging vs chest-x-ray assessment of endothoracal sarcoidosis extent
Z. Ivancevic, K. Mise, S. Jankovic, J. Roglic, I. Juric (Split, Croatia)
| |